Nastech Pharmaceutical Company Inc. Provides Update On Parathyroid Hormone (PTH1-34) Nasal Spray For Treatment Of Osteoporosis
Tue, 05 Dec 2006 08:00 AM EST
... Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) today provided a progress report on the significant clinical development program currently being conducted and planned for the Parathyroid Hormone (PTH1-34) Nasal Spray, which is under development for the treatment of osteoporosis. [click link for full article] ...
Related Topics
- Hormones
- Osteoporosis
- Calcitonin Salmon Nasal Spray
- Mometasone Nasal Spray
- Zolmitriptan Nasal Spray
- Sumatriptan Nasal Spray
- Nicotine nasal spray
- Azelastine Nasal Spray
- Triamcinolone Nasal Inhalation
- Fluticasone Nasal Inhalation
- Beclomethasone Nasal Inhalation
- Cromolyn Nasal Spray
- Budesonide Nasal Inhaler
- Parathyroid Disorders
- Butorphanol Nasal Spray
- Xylometazoline Nasal
- Ipratropium Nasal
- Desmopressin Nose Spray
- Growth Hormone
- Growth Hormones

Not Signed In -


